The Potential Added Value of Impulse Oscillometry in Asthma Monitoring

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this longitudinal observational study is to learn if impulse oscillometry (IOS) has an added value in asthma monitoring in adult asthma patients who are prescribed a change in asthma maintenance therapy. The main questions it aims to answer are: * Is there a difference in the change in IOS parameters and FEV1 respectively, stratified according to change in asthma control test? * Is there a difference in the change in IOS parameters and FEV1 respectively, stratified according to change in other questionnaire such as the asthma control questionnaire and the asthma quality of life questionnaire. * Are the proposed minimal clinically important differences (MCIDs) valid for short follow-up periods (3 - 6 months)? Participants will undergo lung function testing (full lung function, multiple breath nitrogen washout, impulse oscillometry) and questionnaires (asthma control test, asthma control questionnaire, asthma quality of life questionnaire), once during the baseline visit and once during the follow-up visit three to six months later.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adult asthma patients with a scheduled consultation at the outpatient hospital to whom a step-up or step-down of their pharmacological asthma treatment is prescribed

Locations
Other Locations
Belgium
Universitair Ziekenhuis Brussel
RECRUITING
Brussels
Contact Information
Primary
Shane Hanon, Prof. Dr. MD.
Shane.Hanon@uzbrussel.be
02 477 6841
Time Frame
Start Date: 2024-09-01
Estimated Completion Date: 2026-04
Participants
Target number of participants: 50
Treatments
Experimental: Adult asthma patients
Lung function tests (full lung function, multiple breath nitrogen washout, impulse oscillometry) and questionaires (asthma control test, asthma control questionnaire, asthma quality of life questionnaire) will be conducted, once at baseline and once 3 - 6 months later during follow-up.
Related Therapeutic Areas
Sponsors
Leads: Universitair Ziekenhuis Brussel
Collaborators: Vrije Universiteit Brussel

This content was sourced from clinicaltrials.gov